| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.061 | 0.7 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |